
### [MONDO:0004338](http://purl.obolibrary.org/obo/MONDO_0004338)
**Label:** retinal cell cancer

**Subclasses:** [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), 

**Corr. equiv. classes:** [Orphanet:357027](http://www.orpha.net/ORDO/Orphanet_357027), [Orphanet:790](http://www.orpha.net/ORDO/Orphanet_790), [Orphanet:357034](http://www.orpha.net/ORDO/Orphanet_357034), [OMIM:180200](http://purl.obolibrary.org/obo/OMIM_180200), 

**Class expressions from DL-Learner:**

- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0100737](http://purl.obolibrary.org/obo/HP_0100737) (Abnormality of the hard palate) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0030960](http://purl.obolibrary.org/obo/HP_0030960) (Abnormal pupillary morphology) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0030506](http://purl.obolibrary.org/obo/HP_0030506) (Yellow/white lesions of the retina) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0012254](http://purl.obolibrary.org/obo/HP_0012254) (Ewing's sarcoma) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0011885](http://purl.obolibrary.org/obo/HP_0011885) (Hemorrhage of the eye) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0011531](http://purl.obolibrary.org/obo/HP_0011531) (Vitritis) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 62.50%
- [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) and [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 62.50%
- [HP:0007902](http://purl.obolibrary.org/obo/HP_0007902) (Vitreous hemorrhage) and [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) 62.50%
- [HP:0007862](http://purl.obolibrary.org/obo/HP_0007862) (Retinal calcification) and [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) 62.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) 62.50%
- [HP:0004327](http://purl.obolibrary.org/obo/HP_0004327) (Abnormality of the vitreous humor) and [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) 62.50%
- [HP:0003745](http://purl.obolibrary.org/obo/HP_0003745) (Sporadic) and [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) 62.50%


